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Ethanolic Extract of Melia Fructus
Has Anti-influenza A Virus Activity by
Affecting Viral Entry and Viral RNA
Polymerase
Young-Hee Jin, Jang-Gi Choi, Won-Kyung Cho and Jin Yeul Ma*
Korean Medicine Application Center, Korea Institute of Oriental Medicine, Daegu, South Korea
Meliae Fructus (MF) is the dried ripe fruit of Melia toosendan Siebold et Zuccarini,
Meliaceae family. MF is widely used in traditional medicine to treat inflammation and
helminthic infection and has anti-bacterial, anti-oxidant, anti-cancer, anti-inflammatory,
and analgesic activities. However, potential anti-influenza properties of MF have yet to
be investigated. We determined whether an ethanolic extract of MF (EMF) has anti-viral
activity via an EMF pre-, co-, and post-treatment assay, using the Influenza A/PR/8/34
and H3N2 virus on Madin-Darby canine kidney (MDCK) cells. The EMF had anti-
influenza virus activity in pre- and co-treated cells in a dose-dependent manner, but not
in post-treated cell. EMF inhibited the activity of hemagglutinin (HA) and neuraminidase
(NA) of influenza virus. EMF inhibited viral HA, nucleoprotein (NP), matrix protein 2 (M2),
non-structural protein 1 (NS1), polymerase acidic protein (PA), polymerase basic protein
1 (PB1), and polymerase basic protein 2 (PB2) mRNA synthesis at 5 h post infection
(hpi), however, the levels of PA, PB1, and PB2 mRNA were increased in pre- and co-EMF
treated cells compared with control virus-infected and EMF post-treated cells at 18 hpi.
The level of M2 protein expression was also decreased upon pre- and co-treatment
with EMF. The PA protein was accumulated and localized in not only the nucleus but
also the cytoplasm of virus-infected MDCK cells at 18 hpi. Pre-EMF treatment inhibited
the expression of pAKT, which is induced by influenza virus infection, at the stage of virus
entry. We also found that treatment of EMF up-regulated the antiviral protein Mx1, which
may play a partial role in inhibiting influenza virus infection in pre- and co-EMF treated
MDCK cells. In summary, these results strongly suggested that an ethanolic extract of
Meliae Fructus inhibited influenza A virus infection by affecting viral entry, PA proteins
of the RNA polymerase complex, and Mx1 induction and may be a potential and novel
anti-influenza agent.
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INTRODUCTION
Influenza A virus causes seasonal and endemic infection, periodic and unpredictable pandemics,
high morbidity and high mortality to human and several kinds of animals such as birds and
pigs (Taubenberger and Morens, 2008). The Spanish Influenza virus (H1N1) killed around 50
million people in 1918 and was the worst human outbreak (Taubenberger and Morens, 2006).
Other pandemics occurred in 1957 (H2N2), 1968 (H3N2), 1977 (H1N1), 1997 (avian H5N1),
2009 (swine H1N1), and 2013 (avian H7N9) (Horimoto and Kawaoka, 2005; Hsieh et al., 2016).
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Pandemics with high mortality rates have continued to occur, and
thus, novel therapeutic agents are needed (Kilbourne, 2006).
Influenza viruses belong to the Orthomyxoviridae family and
contain a segmented, negative-strand RNA genome (virion RNA,
vRNA). Each genome segment forms a viral ribonucleoprotein
complex (vRNP) containing nucleoprotein (NP) molecules and a
RNA-dependent RNA polymerase (RdRp) complex (polymerase
acidic protein [PA], polymerase basic protein 1 [PB1], and
PB2) (Krug and Aramini, 2009). The major surface protein,
hemagglutinin (HA), binds to the sialic acid receptor on the host’s
cellular surface and facilitates viral entry. The neuraminidase
(NA) viral surface protein promotes the release of virions by
cleaving sialic acid and also impacts viral entry (Su et al., 2009).
Following viral endocytosis and fusion, the vRNPs are released
into the cytoplasm by the influx of H+ through the M2 channel
(uncoating) and then transported into the nucleus to initiate
viral replication (vRNA production) and transcription (viral
mRNA production) (Helenius, 1992; De Clercq and Neyts, 2007).
Viral mRNA is transported to the cytoplasm and translated.
Three surface proteins (HA, NA, and M2) and new vRNP are
transported to the cell surface, and virion packaging and budding
occur (von Itzstein, 2007).
Anti-influenza virus agents can be divided into the following
classes according to their targets: M2 ion channel blockers
(amantadine and rimantadine), NA inhibitors (zanamivir,
oseltamivir, and peramivir), RNA polymerase inhibitors (T705
and flutimide), inosine 5′ monophosphate (IMP) dehydrogenase
inhibitors (ribavirin and viramidine), interferon, and small
interfering (si)RNA (De Clercq and Neyts, 2007). Although these
are currently available as antiviral drugs or still being developed,
there has been increasing reports of drug resistance against
influenza virus due to mutations of surface proteins (Hayden and
de Jong, 2011). To overcome antiviral drug resistance, molecules
that could inhibit virus replication by targeting internal proteins
such as polymerase, NP, and NS1 are being investigated (Patel and
Kukol, 2016).
Meliae Fructus (MF) is the dried ripe fruit of Melia toosendan
Siebold et Zuccarini, family Meliaceae. MF has been used in
Chinese, Japanese, and Korean traditional medicine to treat
acute or chronic inflammation, malaria, and stomach ache
by roundworms as well as insecticide (Tada et al., 1999;
Xie et al., 2008; Park et al., 2014). Studies have recently
indicated that MF has anti-bacterial, anti-oxidant, anti-cancer,
anti-inflammatory, and analgesic activities (Zhang et al., 2007;
Tang et al., 2012). Although toosendanin, a compound of MF
and bark of Melia toosendan Siebold et Zuccarini has been
shown the inhibitory effect on hepatitis C virus infection by
enhancing the alpha-interferon-induced signals and limonoids
from MF inhibits Mycobacterium tuberculosis and Flavivirus
(Watanabe et al., 2011; Sanna et al., 2015), the anti-influenza
virus properties of an ethanolic extract of MF (EMF) has yet
to be investigated. In this study, we investigated whether EMF
has the anti-viral activity using an EMF pre-, co-, and post-
treatment assay of Influenza A/PR/8/34 and H3N2 virus infection
on Madin-Darby canine kidney (MDCK) cells in order to
elucidate the inhibitory mechanism of EMF on influenza A virus
infection.
MATERIALS AND METHODS
Cells and Viruses
Madin-Darby canine kidney (ATCC CCL-34) cells were
maintained in Eagle’s Minimum Essential Medium (EMEM)
(Lonza, Basel, Switzerland) supplemented with 10% fetal
bovine serum (FBS) and antibiotics (100 U/ml penicillin and
100 µg/ml streptomycin) at 37◦C with 5% CO2. Influenza A
viruses, Puerto Rico/8/34 (A/PR/8/34; H1N1, accession no.
CY033584), Green Fluorescent Protein (GFP)-tagged A/PR/8/34
(A/PR/8/34-GFP), and KBPV-VR-32 (H3N2) were propagated
in the allantoic fluid of 10-day-old chicken embryos. We
received A/PR/8/34 and A/PR/8/34-GFP from Dr. Jong-Soo Lee,
College of Veterinary Medicine, Chungnam National University,
Republic of Korea and H3N2 were purchased from Korea Bank
for Pathogenic Viruses. The virus titers were determined by
using a plaque assay, as described previously (Balish et al.,
2013).
Preparation of the Ethanolic Extract of
MF (EMF)
Meliae Fructus was obtained from Yeongcheon hyundai Herbal
Market (Yeongcheon, Korea) and identified by Professor Ki
Hwan Bae, Chungnam National University, Republic of Korea.
Dried MF (30.0 g) was extracted with 390 mL 70% ethanol
in a 37◦C shaking incubator for 24 h. The extract solution
was filtered and concentrated using a rotary vacuum evaporator
(Buchi, Tokyo, Japan). Samples were freeze-dried and stored in
a desiccator at 4◦C before use. Sample acquisition was 5.2 g, and
the yield was 17.5%.
Cell Cytotoxicity MTS Assay
Madin-Darby canine kidney cells (2× 104 cells/well) were seeded
in 96-well tissue culture plates and incubated at 37◦C and 5%
CO2 overnight. EMF was added at indicated concentrations in
Figure 1A. After 24 h incubation, 3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) solutions (Promega, Madison, WI, USA) were added to
each well, and the cells were incubated for one more hour. The
absorbance at 490 nm was recorded using the Glomax Explorer
System (Promega, Madison, WI, USA). The concentration of
EMF that caused the death of 50% of the cells was defined as the
50% cytotoxic concentration (CC50).
Virus Infection and Antiviral Assay
Madin-Darby canine kidney cells were cultured in 96-well plates
at a density of 2 × 104 cells/well for 12 h. For the pre-treatment
assay, before virus infection, the indicated EMF concentrations
were added to the cells and incubated for 6 h. Then, EMF was
removed, and the MDCK cells were washed two times with PBS.
The cells were infected at 10 multiplicity of infection (MOI)
using A/PR/8/34, A/PR/8/34-GFP or H3N2 at 37◦C for 2 h.
For the co-treatment assay, the indicated EMF concentrations
were mixed with 10 MOI A/PR/8/34, A/PR/8/34-GFP or H3N2
and the mixture was incubated at 4◦C for 1 h. MDCK cells
(2 × 104 cells/96 well) were infected with the virus mixture at
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FIGURE 1 | The cytotoxicity of EMF in MDCK cells and a schematic diagram of the anti-influenza virus assay to assess the effect of EMF. (A) To
determine the cytotoxicity of EMF, the viability of MDCK cells were determined using the MTS assay after the treatment of indicated concentrations of EMF for 24 h.
The data represent the mean ± SD based on three replicates in three different experiments. Statistical significance was assessed via one-way ANOVA. P < 0.001.
(B) In the pre-treatment assay, the indicated concentrations of EMF were treated on MDCK cells for 6 h prior to A/PR/8/34, A/PR/8/34-GFP, or H3N2 virus (10 MOI)
infection. In the co-treatment assay, 10 MOI virus and the indicated concentrations of EMF were mixed and incubated at 4◦C for 1 h. MDCK cells were infected with
the virus mixture for 2 h at 37◦C. In the post-treatment assay, MDCK cells were infected with virus for 2 h at 37◦C and were treated with the indicated concentrations
of EMF for the indicated times.
37◦C for 2 h. Afterward, the virus was removed and replaced
by complete EMEM containing 10 µg/mL L-1-Tosylamide-2-
phenylethyl chloromethyl ketone (TPCK)-treated trypsin (Sigma,
St. Louis, MO, USA). The cultures were incubated for the
indicated time at 37◦C and 5% CO2. For the post-treatment
assay, the cells were infected with 10 MOI A/PR/8/34, PR/8/34-
GFP or H3N2 at 37◦C for 2 h. Afterward, the virus was
removed, and cells were treated with indicated concentrations
of EMF in complete EMEM containing 10 µg/mL TPCK-
treated trypsin for the indicated time at 37◦C and 5% CO2
(Figure 1B).
Viral cytopathic effect (CPE) was determined at 24 hpi
by the MTS assay as described above. Viral GFP expression
was observed using a fluorescence microscope (Olympus,
Tokyo, Japan) and measured with a fluorescence spectrometer,
Glomax Explorer System (Promega, Madison, WI, USA). The
50% effective concentration (EC50) values were calculated by
regression analysis.
Hemagglutination (HA) Inhibition Assay
A/PR/8/34 was diluted with PBS to achieve 4 HAU/25 µl
in a round-bottomed 96-well plate and mixed with serially
diluted EMF for 1 h at 4◦C. Chicken red blood cells (cRBCs)
(Innovative Research Inc, Southfield, MI, USA) were added to
each well at a concentration of 0.5% in PBS. After incubation
for 1 h at room temperature, the plate was imaged (Shoji et al.,
2015).
Neuraminidase (NA) Inhibition Assay
Neuraminidase inhibition assay was performed using the
NA-FluorTM Influenza Neuraminidase Assay Kit (Applied
Biosystems, Foster City, CA, USA) as per the manufacturer’s
instructions. Briefly, EMF was serially diluted with assay buffer
in a 96-well black plate. A/PR/8/34 in assay buffer was added
to each well and incubated for 30 min at 37◦C with serially
diluted EMF. Each sample was mixed with 200 µM NA-Fluor
Substrate in a 96-well plate. After 1 h at 37◦C, the reaction was
terminated by adding NA-Fluor stop solution and monitored in a
fluorescence spectrometer (Promega, Madison, WI, USA) using
an excitation wavelength of 365 nm and an emission wavelength
range of 415–445 nm.
Quantitative Real Time-Polymerase
Chain Reaction (qRT-PCR)
Total RNA was extracted from MDCK cell lysates using an
RNeasy mini kit (Qiagen, Hilden, Germany). Total RNA
(500 ng) was used to synthesize cDNA using Accupower
RT-PreMix (Bioneer, Daejeon, Korea). RT-qPCR was performed
using AccuPower R© 2X Greenstar qPCR Master Mix (Bioneer,
Daejeon, Korea) and a CFX96 Touch Real-Time PCR System
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(Bio-Rad, Hercules, CA, USA). The sense and antisense
primer sequences, respectively, used are as follows: HA (5′-
ttgctaaaacccggagacac-3′ and 5′-cctgacgtatttgggcact-3′); NP
(5′-gaatggtgctctctgcttttga-3′ and 5′-tccactttccgtttactctcctg-3′);
M2 (5′-gaaaggagggccttctacgg-3′ and 5′-tcgtcagcatccacagcac-3′);
NS1 (5′-gcgatgccccattccttg-3′ and 5′-atccgctccactatctgctttc-3′);
PA (5′-aagtgccataggccaggtttc-3′ and 5′-cctcatctccattccccatttc-3′);
PB1 (5′-gacaacaaacaccgaaactggag-3′ and 5′-ccatcgcctccaataca
caatc-3′); PB2 (5′-ggtgcttacgggcaatcttc-3′ and 5′-tgttcgtctctcccact
cactatc-3′); canine interferon (IFN)-β (5′-ccagttccagaaggag
gaca-3′ and 5′-tgtcccaggtgaagttttcc-3′); canine Mx1 (5′-gaat
cctgtacccaatcatgtg-3′ and 5′-taccttctcctcatattggct-3′); and canine
β-actin (5′-tgccttgaagttggaaaacg-3′ and 5′-ctggggcctaatgttctcaca-
3′) (Shoji et al., 2015). Relative expression was calculated by the
11Ct method, and β-actin expression served as an internal
reference. Real-time PCR reactions were performed in triplicate.
Immunofluorescence Staining
After 18 hpi, MDCK cells were washed twice with PBS and
fixed with 10% formalin solution in TBS for 10 min. Cells were
permeabilized in 0.3% Triton X-100 in TBS for 15 min and
incubated with a rabbit polyclonal antibody detecting M2, PA
(GeneTex, San Antonio, TX, USA), or phospho-AKT (Ser473)
(Cell Signaling Technology, Danvers, MA, USA) at 4◦C overnight
and with a Alexa Fluor R© 488 goat anti-rabbit IgG antibody
(Thermo Fisher Scientific, Waltham, MA, USA) at 37◦C for 1 h.
Nuclei were visualized by staining with DAPI (1 µg/mL). Images
were captured on a fluorescence microscope (Olympus, Tokyo,
Japan).
Western Blot Analysis
Madin-Darby canine kidney cells (5 × 106 cells/6-well)
were harvested at the indicated time. Equal amounts of
protein lysate (20 µg) in radioimmunoprecipitation assay
(RIPA) buffer were separated by 12% SDS-PAGE. After
transfer, polyvinylidene difluoride (PVDF) membranes were
incubated at room temperature for 1 h with primary antibodies
(1:1000 dilution) against phospho-AKT (Ser473) (Cell Signaling
Technology, Danvers, MA, USA) and β-actin (Cell Signaling
Technology, Danvers, MA, USA). Horseradish peroxidase
(HRP)-conjugated secondary antibodies (1:2000 dilution) were
then incubated at room temperature for 1 h. Protein bands were
detected with an enhanced chemiluminescence reagent (Thermo
Scientific, Waltham, MA, USA) and a ChemiDoc imaging system
(Bio-Rad, Hercules, CA, USA). The relative intensities of protein
bands were analyzed using Image Lab Version 5.2 densitometric
analysis program (Bio-Rad, Hercules, CA, USA).
Statistical Analysis
An unpaired Student’s t-test was used to assess possible significant
differences (a two-tailed p-value) between the treatment and
control groups. One-way analysis of variance (ANOVA) test was
used for comparisons when more than two groups were analyzed.
GraphPad Prism software version 5.0 (GraphPad Software,
San Diego, CA, USA) was used. P < 0.05 were considered
statistically significant.
RESULTS
EMF CC50 Determination on MDCK Cells
We screened anti-influenza A virus activity of traditional herbal
medicine, and we found EMF to possess potent anti-influenza
A virus activity on MDCK cells. MDCK cells were widely
used for the study of influenza virus, because of their high
susceptibility to infection with influenza strains (Gaush and
Smith, 1968).
The cytotoxicity of EMF was assessed using the MTS assay
after 24 h treatment with various EMF concentrations. CC50
value for EMF was 531.8 ± 40.4 µg/ml (Figure 1A). Thus,
all experiments for antiviral effects were performed at EMF
concentrations below CC50 value of 100 µg/ml.
EMF Suppressed Influenza A Virus
Infection on MDCK Cells in Pre- and
Co-treatment Assay
To evaluate anti-influenza A virus activity, we assessed virus-
induced CPE and used a modified GFP assay as previously
described (Talactac et al., 2015). MDCK cells were infected
with A/PR8/34-GFP (10 MOI) for 2 h after 6 h pre-treatment
with the serially diluted concentration of EMF in the pre-
treatment assay. After 24 hpi, EMF treated MDCK cells
significantly reduced GFP expression in a dose dependent
manner (Figures 2A,B). Consistent with these data, MTS
assay data showed that pre-treatment of EMF can protect
MDCK cells from A/PR8/34 and H3N2 virus-induced cell death
in a dose-dependent manner (Figure 2C and Supplementary
Figure 2A). These data suggested that EMF inhibited the
A/PR8/34-virus-induced CPE and GFP expression with an EC50
of 68.2± 6.4 µg/ml.
In the co-treatment assay, serially diluted EMF concentrations
were mixed with A/PR8/34-GFP and incubated at 4◦C for 1 h,
and then MDCK cells were inoculated with the mixture for
2 h. After 24 hpi, we found that EMF had inhibitory activity
against A/PR/8/34-GFP in a dose-dependent manner with
an EC50 value of 48.9 ± 13.4 µg/ml as determined by GFP
expression (Figures 2D,E) and CPE analysis (Figure 2F). It could
inhibit H3N2 virus-induced CPE in a dose-dependent manner
(Supplementary Figure 2B). However, in the post-treatment
assay, EMF showed no inhibitory effect (Supplementary
Figure 1). Therefore, these data indicated that EMF has
anti-influenza A virus activity in the pre- and co-treatment
assays, in a dose-dependent manner, but not in post-treatment
assay.
EMF Has HA and NA Inhibition Activity
The co-treatment assay results indicated that EMF directly
affected influenza virus. Therefore, we evaluated whether EMF
inhibits hemagglutination (HA) activity. The HA inhibition
assay showed that EMF inhibited viral attachment onto cRBCs
at 500 µg/ml (Figure 3A). This result indicated that EMF
inhibits HA activity. Next, we conducted an NA inhibition
assay to determine whether NA activity was impaired by
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FIGURE 2 | EMF inhibited influenza virus infection and cytopathic effect in a dose-dependent manner in pre- and co-treatment assays. (A–C) In the
pre-treatment assay, MDCK cells were pre-treated with serially diluted concentrations of EMF for 6 h prior to infection with the A/PR/8/34-GFP virus (10 MOI). (D–F)
In the co-treatment assay, the serially diluted concentrations of EMF were mixed with 10 MOI A/PR/8/34-GFP and incubated at 4◦C for 1 h. The MDCK cells were
infected with the virus mixture at 37◦C for 2 h. Virus-expressed GFP protein was detected by fluorescence microscopy (upper panel, fluorescence; bottom, phase
contrast microscopy) at 20× magnification (A,D) and by fluorescence spectrometry (B,E) at 24 hpi. Virus-induced CPE in MDCK cells was measured using the MTS
assay at 24 hpi (C,F). The data represent the mean ± SD based on three replicates. All data are representative of three independent experiments. Statistical
significance was assessed via one-way ANOVA. P < 0.001.
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FIGURE 3 | EMF inhibited HA and NA activities of A/PR/8/34.
(A) A/PR/8/34 virus was diluted with PBS at 4 HAU, mixed with serially diluted
concentrations of EMF for 1 h at 4◦C in duplicates. 0.5% cRBCs in PBS were
added to each well and incubated for 1 h at room temperature and imaged.
(B) A/PR/8/34 was incubated with serially diluted EMF for 30 min at 37◦C,
and 200 µM NA-Fluor substrate was added. After 1 h incubation at 37◦C, the
reaction was terminated by adding NA-Fluor stop solution and monitored via
fluorescence spectrometry. Data are presented as the mean ± SD based on
three replicates in three independent experiments. Statistical significance was
assessed via one-way ANOVA. P < 0.001.
EMF. NA activity of A/PR/8/34 was inhibited in a dose-
dependent manner upon EMF treatment with an EC50 value
of 428.2 ± 11.6 µg/ml (Figure 3B), implying that EMF
affects NA activity. Collectively, these data strongly suggested
that EMF inhibits HA and NA activity of influenza virus,
A/PR/8/34.
EMF Impaired Viral mRNA Synthesis
We further investigated whether EMF inhibits viral mRNA
synthesis. After pre-, co-, and post- EMF treatment, at a
concentration of 100 µg/ml, A/PR/8/34-infected MDCK cells
were harvested and relative mRNA expression level of viral genes
at 5 and 18 hpi were assessed by qRT-PCR. HA, NP, M2, and NS1
mRNA synthesis was suppressed in pre- and co-treated MDCK
cells with EMF at 5 and 18 hpi (Figure 4A). Inhibition of mRNA
synthesis was more robust at 5 hpi than at 18 hpi. In post-
treated cells with EMF, EMF did not affect HA, NP, M2, and NS1
mRNA synthesis, consistent with previous data (Supplementary
Figure 1).
Moreover, three subunits of the RdRp complex (PA, PB1, and
PB2) mRNA synthesis were decreased in pre- and co-treated
cells with EMF at 5 hpi, but this was not observed in post-
treated cells (Figure 4B). However, PA, PB1, and PB2 mRNA
synthesis were more increased in pre- and co-treated cells with
EMF at 18 hpi compared with virus infected and post-EMF
treated cells. Our findings suggested that pre- and co-treatment
with EMF inhibits viral mRNA synthesis of HA, NP, M2, NS1,
PA, PB1, and PB2 at 5 hpi, however PA, PB1, and PB2 mRNA
synthesis is enhanced in pre- and co-treated cells with EMF
compared with infected control and EMF post-treated cells at
18 hpi.
EMF Reduced M2 Protein Levels and
Affected PA Protein Localization
To confirm the expression of A/PR/8/34 and H3N2 viral protein
expression in pre-, co-, and post- treated cells with EMF at
100 µg/ml, we performed immunofluorescence analysis after
18 hpi with A/PR/8/34 and H3N2. Viral M2 protein expression
was suppressed in EMF pre- and co-treated cells after 18 hpi
compared with infected control and EMF post-treated cells,
which is consistent with observed M2 mRNA levels (Figure 5A
and Supplementary Figure 2C).
We also examined the expression of PA protein in pre-,
co-, and post-treatment assay with EMF at 18 hpi. PA
proteins were localized in the nuclei of infected MDCK
cells at 18 hpi, as previously demonstrated (Figure 5B and
Supplementary Figure 2D) (Jones et al., 1986). However, PA
protein expression was distributed in the nucleus and cytoplasm
of EMF pre-and co-treated MDCK cells, whereas PA proteins
in post- EMF treated MDCK cells were still localized in the
nucleus.
While M2 protein expression decreased, PA proteins
accumulated and localized in not only the nucleus but also
cytoplasm in influenza-infected cells upon pre- and co-treatment
with EMF at18 hpi. However, there were no differences between
infected post-treated cells with EMF and infected control MDCK
cells.
EMF Inhibited PI3K/AKT Phosphorylation
Induced by Influenza A Virus Infection
Only pre- and co-treatment with EMF suppressed influenza
virus infection, which suggested that EMF affects early events
in infection. It is known that PI3K (phosphatidylinositol 3-
kinase)/AKT (a serine/threonine kinase) phosphorylation occurs
during viral entry (Ehrhardt et al., 2006), so we examined
whether EMF inhibits AKT phosphorylation after A/PR/8/34
infection. After pre-treatment of EMF at 100 µg/ml for 6 h,
MDCK cells were infected with A/PR/8/34, and Western blot
analysis was performed to detect phosphorylated AKT at 5 and
18 hpi (Figure 6A). Influenza virus infection induced increased
AKT phosphorylation (lanes 3 and 7) at 5 and 18 hpi as
previously reported. However, virus-induced phosphorylation
was inhibited by pre-treatment with EMF at 5 and 18 hpi (lanes 4
and 8).
We also used immunofluorescence analysis to confirm this
data (Figure 6B). In pre-EMF treated cells, the number of
cells expressing AKT phosphorylation decreased compared with
control cells at 18 hpi. Therefore, our data confirmed that pre-
EMF treatment decreased phospho-AKT expression induced by
viral infection.
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FIGURE 4 | EMF affected the level of A/PR/8/34 mRNA synthesis in pre- and co-treatment assays. In pre (PRE)-, co (CO)-, and post (POST)-treatment
assays with EMF at 100 µg/ml, A/PR/8/34-infected MDCK cells at 10 MOI were analyzed the relative levels of viral HA, NP, M2, and NS1 mRNA (A) and PA, PB1,
and PB2 mRNA (B) at 5 and 18 hpi via qRT-PCR, normalized to β-actin mRNA. Data are presented as means ± SD based on three replicates and are representative
of three independent experiments. n. d., not detected. V, infected control MDCK cells. Statistical significance was assessed via the Student’s t-test. ∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001.
FIGURE 5 | EMF reduced the M2 protein and localized the PA protein in the nuclei and cytoplasm of infected MDCK cells in pre- and co-treatment
assays. In pre (PRE-EMF)-, co (CO-EMF)-, and post (POST-EMF)-treatment assays with EMF at 100 µg/ml, A/PR/8/34-infected MDCK cells at 10 MOI were fixed at
18 hpi. The green foci indicated the presence of M2 (A) or PA (B) viral proteins (left column), and nuclei were stained with DAPI (middle column). The viral protein and
DAPI images were merged (right column). Data are representative of three independent experiments. A/PR/8/34, virus-infected control MDCK cells. Scale bars,
50 µm (A) and 100 µm (B) at 40× magnification.
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FIGURE 6 | EMF inhibited virus-induced phosphorylation of AKT. MDCK
cells were treated with EMF at 100 µg/ml for 6 h prior to A/PR/8/34 infection
at 10 MOI. (A) MDCK cell lysates were harvested at 5 and 18 hpi, and
phosphorylated AKT protein were detected by Western blot, with β-actin
serving as an internal control. The relative ratio of pAKT/β-actin protein bands
was calculated. M, untreated cells. EMF, EMF-treated cells. V, virus-infected
cells. V + EMF, EMF pre-treated cells prior to virus infection. (B) Cells were
fixed at 18 hpi and stained with the anti-pAKT antibody (left column, green)
and DAPI for nucleus (middle column, blue). The viral protein and DAPI images
were merged (right column). Data are representative of three independent
experiments. Scale bars, 100 µm.
Pre- and Co-treatment with EMF
Increased Antiviral Factor Mx1 at 18 hpi
We examined whether EMF treatment affects the host cell
immune response induced by A/PR/8/34. Particularly, we
analyzed the level of antiviral factors, IFN-β and Mx1 mRNA
in A/PR/8/34 infected MDCK cells upon pre-, co-, and post-
treatment of EMF at 100 µg/ml at 5 and 18 hpi via qRT-PCR.
IFN-β mRNA levels were not different between pre-, co-, and
post-EMF treatment and control MDCK cells at 5 and 18 hpi
(Figure 7A). However, Mx1 mRNA levels were significantly
down-regulated in pre- and co-treated MDCK cells at 5 hpi, but
Mx1 was up-regulated in pre- and co- EMF treated MDCK cells
at 18 hpi compared with control and post-EMF treated MDCK
cells (Figure 7B). Therefore, up-regulation of Mx1 by EMF may
contribute to inhibiting influenza virus infection in pre- and
co-EMF treated MDCK cells at 18 hpi.
DISCUSSION
While MF is known for its anti-bacterial, anti-oxidant, anti-
cancer, anti-inflammatory, and analgesic activities, anti-influenza
virus activity of MF has yet to be reported. In this study, we found
that ethanolic extract of MF demonstrates potent anti-influenza
A virus activity in MDCK cells.
Viral replication was only inhibited in pre- and co- EMF
treated MDCK cells, and not in post-treated cells, at 24 hpi
(Figure 2 and Supplementary Figure 2). These findings suggested
that EMF functions before viral adsorption or during infection
and does not affect post-virus infection.
The surface HA protein of influenza virus binds to the sialic
acid receptor on the host’s cell surface and mediates viral entry.
NA is known to promote the release and spread of progeny
virions and can also enhance HA-mediated viral membrane
fusion and virion infectivity in early stages of influenza virus
replication (Matrosovich et al., 2004; Su et al., 2009). We found
EMF inhibited HA and NA activity (Figure 3), implying that
the inhibition of virus infection by EMF results from blocking
the HA-sialic acid receptor interaction and NA activity in the
early stages of infection. The PI3K/AKT signaling pathway
regulates viral entry, and the inhibition of AKT kinase activity
suppresses viral entry and replication (Ehrhardt et al., 2006;
Hirata et al., 2014). We found that EMF treatment decreased AKT
phosphorylation (Figure 6). Thus, EMF treatment interferes with
an early process of virus uptake. It has previously been shown that
limonoid compounds from MF inhibit West Nile virus infection
only when added during virus infection, suggesting that the
inhibition occurs at the entry or an early stages of life cycle (Sanna
et al., 2015).
Ethanolic extract of MF treatment also affected viral RNA
polymerase including PA, PB1, and PB2 mRNA synthesis and
PA protein localization. EMF inhibited viral HA, NP, M2, NS1,
PA, PB1, and PB2 viral mRNA synthesis at 5 hpi, but PA, PB1,
and PB2 mRNA synthesis was higher in EMF pre- and co-
treated cells compared with virus-infected and EMF post-treated
cells at 18 hpi (Figure 4). Moreover, M2 protein expression
was decreased upon pre- and co-treatment with EMF, but
PA proteins were accumulated and localized in not only the
nucleus but also the cytoplasm of infected cells at 18 hpi upon
pre- and co- EMF treatment (Figure 5 and Supplementary
Figure 2B).
Polymerase basic proteins 1 are essential for viral RNA
polymerase activity, PB2 proteins recognize and bind to host
5′ mRNA cap structure involved in transcription initiation,
and PA proteins possess endonucleolytic activity for the viral
cap-snatching process (Rodriguez-Frandsen et al., 2015). PA,
PB1, and PB2 proteins are predominantly associated with the
nuclei of influenza virus infected cells (Jones et al., 1986).
It has been reported that PA proteins induce the proteolytic
process to decrease its own accumulation, and the nuclear
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FIGURE 7 | EMF up-regulated antiviral protein Mx1 in pre- and co- treatment assays. In pre (PRE)-, co (CO)-, and post (POST)-treatment assays with EMF at
100 µg/ml, A/PR/8/34-infected-MDCK cells at 10 MOI were analyzed for the relative mRNA level of antiviral factors, IFN-β (A) and Mx1 (B) at 5 and 18 hpi using
qRT-PCR, normalized to β-actin mRNA. Data are presented as mean ± SD based on three replicates and are representative of three independent experiments.
MOCK, untreated cells. EMF, 100 µg/ml EMF treated cells. V, infected control MDCK cells. n. d., not detected. Statistical significance was assessed via the Student’s
t-test. ∗P < 0.05; ∗∗P < 0.01.
transport of PA proteins could be a prerequisite for proteolysis
(Sanz-Ezquerro et al., 1995, 1996). Moreover, ability of PA
proteins-mediated induction of proteolysis is linked to the
replication activity of the polymerase (Perales et al., 2000).
Therefore, our data suggested that EMF impaired the proteolytic
ability, the nuclear transport and the polymerase activity of
PA proteins, resulting in accumulation of PA proteins in the
cytoplasm of influenza virus infected cells and inhibition of
virus replication. Because PA proteins of the RNA polymerase
complex are promising targets for anti-influenza virus agents,
elucidating the mechanism of impaired PA function by EMF is
critical.
Pre-and co-treatment with EMF increased the antiviral
protein Mx1 at 18 hpi in spite of the lower level of Mx1
at 5 hpi. Mx1 proteins are important antiviral factors against
RNA viruses including influenza viruses at an early stage in
their life cycle (Haller et al., 2007). Mx1 inhibits influenza
virus by disrupting the PB2–NP protein interaction, interfering
with ribonucleoprotein complex assembly, and decreasing viral
polymerase activity (Verhelst et al., 2012). Thus, up-regulation of
Mx1 by EMF may play an important role in inhibiting infection in
EMF pre-and co- treated cells. Interestingly, Mx1 gene expression
is induced by type I and III IFN, but not directly by viruses (Haller
et al., 2015). However, EMF treatment affected the level of Mx1
mRNA, not IFN-β. Thus, it will be interesting to find the Mx1-
inducing factor and the mechanism of upregulation upon EMF
treatment.
In summary, our study suggested that an ethanolic extract of
Meliae Fructus inhibited influenza A virus infection by affecting
viral entry, PA proteins of the RNA polymerase complex, and
Mx1 induction. Further investigation is needed to characterize
active compounds and to elucidate their specific mechanism
against influenza A virus. It may be helpful to develop potential
candidates for novel anti-influenza agent.
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